ABSTRACT
Background Typical electrocardiogram (ECG) features of apical hypertrophic cardiomyopathy (ApHCM) include tall R waves and deep or giant T-wave inversion in the precordial leads, but these features are not always present. We tested whether explainable advanced ECG (A-ECG) could accurately diagnose ApHCM.
Methods A-ECG analysis was performed on standard resting 12-lead ECGs in patients with ApHCM (n=75 overt, n=32 relative [<15mm hypertrophy]), a subgroup of which underwent cardiovascular magnetic resonance, n=92), and comparator subjects (n=2449), including healthy volunteers (n=1672), patients with coronary artery disease (n=372), left ventricular electrical remodelling (n=108), ischemic (n=114) or non-ischemic cardiomyopathy (n=57), and asymmetrical septal hypertrophy (ASH) HCM (n=126).
Results Multivariable logistic regression identified four A-ECG measures that together discriminated ApHCM from other diseases with high accuracy (area under the receiver operating characteristics curve (AUC) [bootstrapped 95% confidence interval] 0.982 [0.965– 0.993]. Linear discriminant analysis also diagnosed ApHCM with high accuracy (AUC 0.989 [0.986–0.991]).
Conclusion Explainable A-ECG has excellent diagnostic accuracy for ApHCM, even when the hypertrophy is relative, with A-ECG analysis providing incremental diagnostic value over imaging alone. The electrical (ECG) and anatomical (wall thickness) disease features do not completely align, suggesting future diagnostic and management strategies may incorporate both features.
Competing Interest Statement
TTS is owner and founder of Nicollier-Schlegel SARL, which performs ECG interpretation consultancy using software that can quantify the advanced ECG measures used in the current study. TTS and MU are owners and founders of Advanced ECG Systems, a company that is developing commercial applications of advanced ECG technology used in the current study.
Funding Statement
R.K.H and G.T. are supported by the British Heart Foundation (grant numbers FS/17/82/33222 and FS/CRTF/21/24128 respectively). J.W.M. is funded by a National Institute of Health Research Clinical Doctoral Research Fellowship (ICA-CDRF-2016-02-068). G.C. is supported by the National Institute for Health Research Rare Diseases Translational Research Collaboration (NIHR RD-TRC, #171603) and by NIHR University College London Hospitals Biomedical Research Centre. JCM is directly and indirectly supported by the University College London Hospitals NIHR Biomedical Research Centre and Biomedical Research Unit at Barts Hospital, respectively.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NHS REC and HRA
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data can be provided upon reasonable request.
NON-STANDARD ABBREVIATIONS AND ACRONYMS
- A-ECG
- Advanced electrocardiogram
- ApHCM
- Apical hypertrophic cardiomyopathy
- ASH
- Asymmetrical septal hypertrophy
- AUC
- Area under the curve
- CMR
- Cardiac magnetic resonance
- ECG
- Electrocardiogram
- FWHM
- Full-width half-maximum
- HCM
- Hypertrophic cardiomyopathy
- HRA
- Health Research Authority
- LDA
- Linear discriminant analysis
- LGE
- Late gadolinium enhancement
- LV
- Left ventricle / ventricular
- LVER
- Left ventricular electrical remodelling
- LVH
- left ventricular hypertrophy
- MWT
- Maximum wall thickness
- NHS REC
- National Health Service Research Ethics Council
- SPECT
- Single-photon emission computerized tomography
- SVD
- Singular value decomposition
- VCG
- Vectorcardiogram
